{
  "case_id": "Case_11",
  "model_id": "openai/gpt-4o-mini",
  "content": "{\n    \"primary_diagnosis\": {\n        \"name\": \"Hemolytic Anemia due to G6PD Deficiency\",\n        \"confidence\": 0.85,\n        \"icd_code\": \"D55.0\",\n        \"reasoning\": \"The patient's symptoms of jaundice, dark urine, and fatigue along with the recent initiation of semaglutide raise suspicion for hemolytic anemia, particularly in the context of potential G6PD deficiency which is more common in Middle Eastern populations.\"\n    },\n    \"differential_diagnoses\": [\n        {\n            \"name\": \"Acute Liver Disease\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"K70.9\",\n            \"reasoning\": \"The yellowing of the skin and sclera could also indicate liver issues, although the rapid onset is more suggestive of hemolysis.\"\n        },\n        {\n            \"name\": \"Acute Kidney Injury\",\n            \"confidence\": 0.05,\n            \"icd_code\": \"N17.9\",\n            \"reasoning\": \"Dark urine can suggest renal involvement, although this is less likely without other renal symptoms.\"\n        },\n        {\n            \"name\": \"Medication-Induced Hemolysis\",\n            \"confidence\": 0.1,\n            \"icd_code\": \"T88.0\",\n            \"reasoning\": \"Semaglutide could potentially cause adverse effects leading to hemolysis, though this is rare and less supported.\"\n        }\n    ],\n    \"key_findings\": [\n        \"Jaundice\",\n        \"Mild splenomegaly\"\n    ],\n    \"diagnostic_tests\": [\n        {\n            \"test\": \"CBC with Reticulocyte Count\",\n            \"purpose\": \"To assess for anemia and reticulocyte response indicating hemolysis\",\n            \"priority\": \"immediate\"\n        },\n        {\n            \"test\": \"G6PD Enzyme Activity Test\",\n            \"purpose\": \"To confirm G6PD deficiency\",\n            \"priority\": \"urgent\"\n        },\n        {\n            \"test\": \"Liver Function Tests\",\n            \"purpose\": \"To evaluate liver status and rule out liver disease\",\n            \"priority\": \"routine\"\n        }\n    ],\n    \"management_plan\": {\n        \"immediate_actions\": [\n            \"Administer IV fluids to manage potential dehydration\",\n            \"Consider blood transfusion if hemoglobin critically low\"\n        ],\n        \"medications\": [\n            {\n                \"drug\": \"Folic Acid\",\n                \"dose\": \"1 mg\",\n                \"route\": \"PO\",\n                \"duration\": \"Indefinite as needed\",\n                \"rationale\": \"To support erythropoiesis in the setting of hemolytic anemia.\"\n            }\n        ],\n        \"monitoring\": [\n            \"Complete blood count and reticulocyte levels\",\n            \"Daily until stabilization\"\n        ],\n        \"consultations\": [\n            {\n                \"specialty\": \"Hematology\",\n                \"urgency\": \"urgent\",\n                \"reason\": \"To evaluate and manage the suspected hemolytic anemia.\"\n            }\n        ]\n    },\n    \"red_flags\": [\n        \"Severe anemia requiring transfusion\",\n        \"Signs of acute renal failure\"\n    ],\n    \"patient_education\": [\n        \"Importance of avoiding certain medications that can trigger hemolysis.\",\n        \"Recognize symptoms of worsening anemia or jaundice.\"\n    ],\n    \"follow_up\": {\n        \"timing\": \"1 week after initial evaluation or sooner if symptoms worsen\",\n        \"conditions\": \"Any worsening jaundice or significant fatigue\"\n    },\n    \"confidence_in_assessment\": 0.8,\n    \"uncertainties\": [\n        \"Confirmation of G6PD deficiency\",\n        \"Potential interactions with semaglutide\"\n    ]\n}",
  "latency": 11.448616981506348,
  "timestamp": "2025-08-10T01:26:17.547703",
  "cached_at": "2025-08-10T01:26:17.547712"
}